James P Mackin

CIK 1408470 · President & CEO · last filed 2026-08-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$33.76M
Companies
5
Total Filings
94
Lifetime Open-Market Net
-$30.75M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address
ARTIVION, INC.
1655 ROBERTS BLVD, NW
KENNESAW, GA 30144
Related Filers
CRYOLIFE INC — 78 joint filings, latest 2026-08-20
MEDTRONIC INC — 15 joint filings, latest 2010-11-02
Wright Medical Group N.V. — 4 joint filings, latest 2020-11-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AORT President & CEO 877,275 $22.71 $19.92M -$18.86M 32 2026-08-20
CRY President & CEO 333,647 $15.72 $5.24M -$11.49M 33 2021-05-04
Wright Medical Group N.V. (WMGI) Delisted Director 11,720 — — $0 1 2019-07-30
Wright Medical Group N.V. (WMGIZ) Delisted Director 7,804 — — $0 1 2018-07-26
MDT SVP & Pres CRDM 97,790 $87.83 $8.59M -$398.1K 14 2010-11-02

Recent Filings · Page 2 of 10

94 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-03 AORT Notice (144) −30,921 -$1.41M EDGAR
2025-12-03 AORT Mixed — -$492.8K EDGAR
2025-12-02 AORT Notice (144) −30,921 -$1.43M EDGAR
2025-11-14 AORT Sell (S) −34,210 -$1.57M EDGAR
2025-11-13 AORT Notice (144) −34,210 -$1.57M EDGAR
2025-11-12 AORT Notice (144) −17,580 -$784.4K EDGAR
2025-11-12 AORT Sell (S) −17,580 -$784.4K EDGAR
2025-08-19 AORT Sell (S) −12,500 -$529.0K EDGAR
2025-08-15 AORT Notice (144) −12,500 -$529.0K EDGAR
2025-03-10 AORT Mixed +102,877 -$561.3K EDGAR
Showing 11–20 of 94
Page 2 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.